ArticleScientific reports2015

WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients.

Di Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.